| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.18 | 8e-09 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-08 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-08 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.16 | 7e-08 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-06 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-06 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-06 |